Latest News
From the Journals
Statins cut vascular events in elderly patients
Analysis challenges current practice of discontinuation after age 75 years.
From the Journals
Compounded pain creams no better than placebo creams in localized chronic pain
At 1 month, creams specifically formulated for neuropathic, nociceptive, or mixed pain had no effect beyond placebo.
From the Journals
Mild aerobic exercise speeds sports concussion recovery
Subsymptom levels of aerobic exercise shortened recovery time, compared with stretching, in adolescent athletes.
Feature
Winners and losers under bold Trump plan to slash drug rebate deals
“A shadowy system of kickbacks,” was how Health and Human Services Secretary Alex Azar described the current system in a speech on Feb. 1.
Feature
CMS proposing more flexibility in Medicare Advantage, Part D
Agency is encouraging plan sponsors “to provide lower cost sharing for opioid reversal agents such as naloxone.”
From the Journals
Shifting drugs from Part B to Part D could be costly to patients
The impact would vary based on the drug, as well as patients’ insurance coverage in addition to Medicare.
Latest News
AHA report highlights CVD burden, declines in smoking, sleep importance
Nearly half of Americans now have high blood pressure, in part due to the 2017 redefinition of hypertension.
Latest News
Aerobic exercise may mitigate age-related cognitive decline
Among adults with below-average fitness, aerobic exercise significantly improves executive function, a randomized trial finds.
Literature Review
Clinical benefits persist 5 years after thymectomy for myasthenia gravis
Patients with generalized nonthymomatous myasthenia gravis who undergo thymectomy may have better long-term clinical outcomes and require less...
Conference Coverage
Mild OSA spontaneously resolves in about one-third of young children
The presence of laryngomalacia did not affect the rate of OSA resolution in this cohort of patients.
Feature
Phase 3 studies of antiamyloid Alzheimer’s drug crenezumab stopped
The molecule will continue to be tested in a study of familial Alzheimer’s in Colombia.